Clinical Trial Update: Study Evaluating Nelotanserin for Treatment of REM Sleep Behavior Disorder in Subjects With Dementia (DLB or PDD) [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating nelotanserin for REM Sleep Behavior Disorder in patients with dementia-related conditions has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dementia with Lewy Bodies
• Parkinson Disease Dementia
• Rem Sleep Behavior Disorder

Drugs mentioned

• nelotanserin (nelotanserin)

Snippet

Sponsor: Axovant Sciences Ltd. | Conditions: Dementia With Lewy Bodies, REM Sleep Behavior Disorder | Phase 2 | Status: COMPLETED | Results posted: 2020-05-20